• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数轻度降低的急性心力衰竭住院患者入院时功能性二尖瓣反流严重程度与一年结局的关系。

Relationship between the severity of functional mitral regurgitation at admission and one-year outcomes in patients hospitalized for acute heart failure with mildly reduced ejection fraction.

机构信息

Department of Cardiology, The Second Affiliated Hospital of Shenzhen University (The People's Hospital of Baoan Shenzhen), Shenzhen, 518100, China.

Graduate School, Guangdong Medical University, Zhanjiang, 524000, China.

出版信息

BMC Cardiovasc Disord. 2024 Jul 13;24(1):357. doi: 10.1186/s12872-024-04017-4.

DOI:10.1186/s12872-024-04017-4
PMID:39003444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11245784/
Abstract

BACKGROUND

The epidemiological distribution of functional mitral regurgitation (FMR) in heart failure (HF) and mildly reduced ejection fraction (HFmrEF) patients and its impact on outcomes remains unclear. We attempt to investigate the prognosis of FMR in patients with HFmrEF.

METHODS

The HF center registry study is a prospective, single, observational study conducted at the Second Affiliated Hospital of Shenzhen University, where 2330 patients with acute HF (AHF) were enrolled and 890 HFmrEF patients were included in the analysis. The patients were stratified into three categories based on the severity of FMR: none/mild, moderate, and moderate-to-severe/severe groups. Subsequently, a comparison of the clinical characteristics among these groups was conducted, along with an assessment of the incidence of the primary endpoint (comprising all-cause mortality and readmission for HF) during a one-year follow-up period.

RESULTS

The one-year follow-up results indicated that the primary composite endpoint occurrence rates in the three groups were 23.5%, 32.9%, and 36.5%, respectively. The all-cause mortality rates in the three groups were 9.3%, 13.7%, and 16.4% respectively. Survival analysis demonstrated a statistically significant difference in the occurrence rates of the primary composite endpoint and all-cause mortality among the three groups (P < 0.05). Multifactor Cox regression revealed that moderate FMR and moderate-to-severe/severe FMR were independent risk factors for adverse clinical prognosis in HFmrEF patients, with hazard ratios and 95% confidence intervals of 1.382 (1.020-1.872, P = 0.037) and 1.546 (1.092-2.190, P = 0.014) respectively.

CONCLUSIONS

Moderate FMR and moderate-to-severe/severe FMR independently predict an unfavorable prognosis in patients with HFmrEF.

摘要

背景

射血分数轻度降低的心衰(HFmrEF)患者中功能性二尖瓣反流(FMR)的流行病学分布及其对结局的影响尚不清楚。我们试图研究 FMR 在 HFmrEF 患者中的预后。

方法

HF 中心登记研究是一项前瞻性、单中心、观察性研究,在深圳大学第二附属医院进行,共纳入 2330 例急性心衰(AHF)患者,其中 890 例 HFmrEF 患者纳入分析。根据 FMR 的严重程度将患者分为三组:无/轻度、中度和中重度/重度。随后,比较三组之间的临床特征,并评估一年随访期间主要终点(包括全因死亡率和因心衰再住院)的发生率。

结果

一年随访结果显示,三组的主要复合终点发生率分别为 23.5%、32.9%和 36.5%,三组的全因死亡率分别为 9.3%、13.7%和 16.4%。生存分析显示三组主要复合终点和全因死亡率的发生率存在统计学差异(P<0.05)。多因素 Cox 回归显示,中度 FMR 和中重度/重度 FMR 是 HFmrEF 患者不良临床预后的独立危险因素,风险比和 95%置信区间分别为 1.382(1.020-1.872,P=0.037)和 1.546(1.092-2.190,P=0.014)。

结论

中度 FMR 和中重度/重度 FMR 独立预测 HFmrEF 患者预后不良。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abd/11245784/8f774e715eee/12872_2024_4017_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abd/11245784/f22d19dbf44f/12872_2024_4017_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abd/11245784/dc10b79c9d42/12872_2024_4017_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abd/11245784/22efb330c130/12872_2024_4017_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abd/11245784/5531cc36387d/12872_2024_4017_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abd/11245784/8f774e715eee/12872_2024_4017_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abd/11245784/f22d19dbf44f/12872_2024_4017_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abd/11245784/dc10b79c9d42/12872_2024_4017_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abd/11245784/22efb330c130/12872_2024_4017_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abd/11245784/5531cc36387d/12872_2024_4017_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2abd/11245784/8f774e715eee/12872_2024_4017_Fig5_HTML.jpg

相似文献

1
Relationship between the severity of functional mitral regurgitation at admission and one-year outcomes in patients hospitalized for acute heart failure with mildly reduced ejection fraction.射血分数轻度降低的急性心力衰竭住院患者入院时功能性二尖瓣反流严重程度与一年结局的关系。
BMC Cardiovasc Disord. 2024 Jul 13;24(1):357. doi: 10.1186/s12872-024-04017-4.
2
Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction.射血分数保留或降低的急性失代偿性心力衰竭患者出院时功能性二尖瓣反流及其结局。
Eur J Heart Fail. 2016 Aug;18(8):1051-9. doi: 10.1002/ejhf.562. Epub 2016 May 23.
3
Functional Mitral Regurgitation Predicts Short-Term Adverse Events in Patients With Acute Heart Failure and Reduced Left Ventricular Ejection Fraction.功能性二尖瓣反流可预测急性心力衰竭且左心室射血分数降低患者的短期不良事件。
Am J Cardiol. 2017 Oct 15;120(8):1344-1348. doi: 10.1016/j.amjcard.2017.07.023. Epub 2017 Jul 25.
4
Prognostic impact of moderate mitral regurgitation on hospitalized heart failure patients with preserved ejection fraction: A report from the JASPER registry.中度二尖瓣反流对射血分数保留的住院心力衰竭患者的预后影响:来自JASPER注册研究的报告。
Heart Vessels. 2020 Aug;35(8):1087-1094. doi: 10.1007/s00380-020-01581-5. Epub 2020 Mar 19.
5
Ischemic or Nonischemic Functional Mitral Regurgitation and Outcomes in Patients With Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction.射血分数保留或降低的急性失代偿性心力衰竭患者的缺血性或非缺血性功能二尖瓣反流及其预后
Am J Cardiol. 2017 Sep 1;120(5):809-816. doi: 10.1016/j.amjcard.2017.05.051. Epub 2017 Jun 15.
6
Clinical Implications of Functional Mitral Regurgitation Severity in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF).射血分数降低的心力衰竭(HFrEF)患者中功能性二尖瓣反流严重程度的临床意义
Med Arch. 2022 Feb;76(1):17-22. doi: 10.5455/medarh.2022.76.17-22.
7
Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fraction.射血分数轻度降低的心力衰竭伴心房颤动的预后和治疗策略。
Eur J Prev Cardiol. 2024 Aug 22;31(11):1372-1384. doi: 10.1093/eurjpc/zwae185.
8
Severity of Functional Mitral Regurgitation on Admission for Acute Decompensated Heart Failure Predicts Long-Term Risk of Rehospitalization and Death.急性失代偿性心力衰竭入院时功能性二尖瓣反流的严重程度预测长期再住院和死亡风险。
J Am Heart Assoc. 2022 Jan 4;11(1):e022908. doi: 10.1161/JAHA.121.022908. Epub 2021 Dec 22.
9
Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction.介入治疗前三尖瓣反流对射血分数严重降低患者MitraClip治疗结局的影响。
Open Heart. 2020 Mar 15;7(1):e001203. doi: 10.1136/openhrt-2019-001203. eCollection 2020.
10
Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China.射血分数处于中等范围的心衰的临床特征与预后:来自中国一项多中心注册研究的见解
BMC Cardiovasc Disord. 2019 Sep 2;19(1):209. doi: 10.1186/s12872-019-1177-1.

引用本文的文献

1
Comparison of clinical outcomes in patients with ST-segment elevation myocardial infarction among preserved, mid-range, and reduced ejection fraction.射血分数保留、中等范围和降低的ST段抬高型心肌梗死患者临床结局的比较。
Heart Vessels. 2025 May 13. doi: 10.1007/s00380-025-02558-y.

本文引用的文献

1
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry.射血分数保留、轻度降低与降低的心衰患者的全面特征分析——来自 ESC-HFA EORP 心衰长期注册登记研究的结果
Eur J Heart Fail. 2022 Feb;24(2):335-350. doi: 10.1002/ejhf.2408. Epub 2022 Jan 10.
2
Severity of Functional Mitral Regurgitation on Admission for Acute Decompensated Heart Failure Predicts Long-Term Risk of Rehospitalization and Death.急性失代偿性心力衰竭入院时功能性二尖瓣反流的严重程度预测长期再住院和死亡风险。
J Am Heart Assoc. 2022 Jan 4;11(1):e022908. doi: 10.1161/JAHA.121.022908. Epub 2021 Dec 22.
3
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
4
Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial.达格列净治疗射血分数保留和轻度降低的心衰:DELIVER 试验的原理和设计。
Eur J Heart Fail. 2021 Jul;23(7):1217-1225. doi: 10.1002/ejhf.2249. Epub 2021 Jun 9.
5
Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017.1990 年至 2017 年,195 个国家和地区心力衰竭的负担及其根本原因。
Eur J Prev Cardiol. 2021 Dec 29;28(15):1682-1690. doi: 10.1093/eurjpc/zwaa147.
6
Prevalence and Prognostic Significance of Mitral Regurgitation in Acute Decompensated Heart Failure: The ARIC Study.在急性失代偿性心力衰竭中二尖瓣反流的流行情况和预后意义:ARIC 研究。
JACC Heart Fail. 2021 Mar;9(3):179-189. doi: 10.1016/j.jchf.2020.09.015. Epub 2020 Dec 9.
7
Functional mitral regurgitation.功能性二尖瓣反流。
Curr Opin Cardiol. 2020 Sep;35(5):464-473. doi: 10.1097/HCO.0000000000000770.
8
Still no benefit of MitraClip in MITRA-FR.在MITRA-FR研究中,MitraClip仍未显示出益处。
Nat Rev Cardiol. 2019 Nov;16(11):649. doi: 10.1038/s41569-019-0280-4.
9
Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years.经皮修复或药物治疗二尖瓣关闭不全的 2 年结果。
Eur J Heart Fail. 2019 Dec;21(12):1619-1627. doi: 10.1002/ejhf.1616. Epub 2019 Nov 18.
10
Effects of the Angiotensin-Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta-Analysis.血管紧张素受体脑啡肽酶抑制剂对心脏逆重构的影响:荟萃分析。
J Am Heart Assoc. 2019 Jul 2;8(13):e012272. doi: 10.1161/JAHA.119.012272. Epub 2019 Jun 26.